Takeda Pharmaceutical TAK
NYSE TAK
$17.86 -0.01 (-0.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Takeda Pharmaceutical (TAK) Invested Capital (2017 - 2026)

Updated

Takeda Pharmaceutical's Invested Capital was $48.11 billion in the quarter ended Jun 30, 2026, down 1.5% from $48.87 billion a year earlier and down 36.8% from the prior quarter.

Analysis

Takeda Pharmaceutical (TAK) Invested Capital (2017 - 2026) Analysis & Trends

For the year ended Mar 31, 2026, Invested Capital at Takeda Pharmaceutical came in at $79.33 billion, up 8.7% from the prior year.

  • Invested Capital shows a five-year compound annual growth rate of -3.5% (years ended Mar 2021 to Mar 2026).
  • In earlier years, Invested Capital was $73.01 billion in the year ended Mar 31, 2025 (-11.5%), $82.47 billion in the year ended Mar 31, 2024 (+5.3%), $78.34 billion in the year ended Mar 31, 2023 (-12.3%) and $89.28 billion in the year ended Mar 31, 2022 (-5.7%).
  • The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Invested Capital since the quarter ended Dec 31, 2023.
  • Compared with a year earlier, Invested Capital was higher in three of the last six quarters, with an average decline of 0.6%.
  • The best year-over-year quarter for Invested Capital over five years was the quarter ended Dec 31, 2024 (growth of 6.2%); the worst was the quarter ended Mar 31, 2025 (a decline of 9.2%).
  • Per Business Quant data, TAK's Invested Capital in the three quarters before the quarter ended Jun 30, 2026 was $76.15 billion (quarter ended Mar 31, 2026), $51.43 billion (quarter ended Dec 31, 2025) and $49.94 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 88.79 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 134.01 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 64.89 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 95.89 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 79.44 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 50.26 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 68.99 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 38.08 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 148.69 Bn
10 Takeda Pharmaceutical 2.59 Bn -23.92 Bn 5.10 Bn 48.11 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 48.11 Bn
Mar 31, 2026 76.15 Bn
Dec 31, 2025 51.43 Bn
Sep 30, 2025 49.94 Bn
Jun 30, 2025 48.87 Bn
Mar 31, 2025 72.90 Bn
Dec 31, 2024 50.22 Bn
Jun 30, 2024 51.80 Bn
Mar 31, 2024 80.26 Bn
Dec 31, 2023 47.29 Bn
Sep 30, 2023 51.09 Bn
Jun 30, 2023 52.80 Bn
Mar 31, 2023 80.01 Bn
Dec 31, 2022 45.00 Bn
Sep 30, 2022 49.43 Bn
Jun 30, 2022 49.93 Bn
Mar 31, 2022 86.25 Bn
Jun 30, 2021 50.55 Bn
Mar 31, 2021 94.84 Bn
Dec 31, 2020 45.32 Bn
API Access

Takeda Pharmaceutical Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=TAK&period=max&api_key=YOUR_API_KEY